MedPath

Investigating the limits of reversibility of type 2 diabetes

Completed
Conditions
Diabetic Control, Nutrition, Obesity
Nutritional, Metabolic, Endocrine
Non-insulin-dependent diabetes mellitus
Registration Number
ISRCTN88634530
Lead Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
34
Inclusion Criteria

1. Type 2 diabetes of < 4 years or > 8 years duration
2. HbA1c < 80 mmol/l / 9.5%
3. BMI 28-40kg/m2
4. Age 25-80 years
5. Stable weight for previous 6 months (within 5kg)
6. Male and female participants

Exclusion Criteria

1. Current treatment with thiazolidinediones, GLP-1 agonists or steroids
2. Renal or hepatic dysfunction
3. Contraindications to MRI
4. Alcohol consumption > 3 units per day for women and > 4 units per day for men
5. Allergy to soybean or eggs
6. Highly restrictive diet

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Restated primary outcome measures as of 31/07/2015:<br>Fasting plasma glucose at 6 months in the group achieving non-diabetic levels at 10 weeks (following VLCD and return to normal eating)<br><br>Previous primary outcome measures:<br>Beta cell function measured at baseline, 8 weeks and 8 months
Secondary Outcome Measures
NameTimeMethod
Added 31/07/2015:<br>Change in beta cell function from 10 weeks to 6 months
© Copyright 2025. All Rights Reserved by MedPath